Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 578
Quick answer
578 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7161003
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted -
US 7160887
Aromatic amine derivatives, their production and use
granted -
US 7160868
Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
granted -
US 7160726
Compositions comprising conditioned cell culture media and uses thereof
granted -
US 7160375
Aqueous glittering color material composition
granted -
US 7161059
Human hookworm model and method for maintaining human hookworm in a non-human primate
granted -
US 7160722
Master bone formation transcription factor: compositions and methods of use
granted -
US 7160867
Rapamycin carbohydrate derivatives
granted -
US 7160984
Process for preparing glycopeptide derivatives
granted -
US 7161012
Processes for preparing amorphous atorvastatin hemi-calcium
granted -
US 7160720
CHAMP—a novel cardiac helicase-like factor
granted -
US 7163925
p16 expression constructs and their application in cancer therapy
granted -
US 7163673
Sunscreen reagents from hydroxy-substituted acylglycerides
granted -
US 7164000
RANTES mutants and therapeutic applications thereof
granted -
US 7163678
Reovirus for the treatment of ral-mediated cellular proliferative disorders
granted -
US 7163946
5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
granted -
US 7163935
Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
granted -
US 7163824
Regulation of endogenous gene expression in cells using zinc finger proteins
granted -
US 7163818
Bacteriophage having multiple host range
granted -
US 7163934
Methods for treating delirium glucocorticoid receptor-specific antagonists
granted -
US 7163806
Somatic cells with ablated PrP gene and methods of use
granted -
US 7163700
Amorphous drug beads
granted -
US 7163686
Protein A based binding domains with desirable activities
granted -
US 7166619
Prenylation inhibitors and methods of their synthesis and use
granted -
US 7166721
Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates
granted -
US 7166588
Derivatives and analogs of galanthamine
granted -
US 7166584
Cholesterol transport gene
granted -
US 7166450
Hyaluronan synthase gene and uses thereof
granted -
US 7166578
Orally administered peptides synergize statin activity
granted -
US 7166762
Method of constructing heart failure model animal
granted -
US 7166704
Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer
granted -
US 7169384
Tumor suppressor CAR-1
granted -
US 7169411
Composition for delivery of biological agents and methods for the preparation thereof
granted -
US 7169779
Inhibitors of p38
granted -
US 7169801
Histone deacetylase inhibitors
granted -
US 7169800
Imidazole compositions useful as inhibitors of protein kinases
granted -
US 7169798
Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases
granted -
US 7169815
3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
granted -
US 7169799
Process for producing crystal
granted -
US 7169726
Catalyst for isomerization of solid fischer-tropsch paraffins and method for its production
granted -
US 7169594
Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
granted -
US 7173005
Insulin and IGF-1 receptor agonists and antagonists
granted -
US 7173007
Therapy for microbial infections
granted -
US 7172768
Storage stable powder compositions of interleukin-4 receptor
granted -
US 7173027
Receptor selective cannabimimetic aminoalkylindoles
granted -
US 7173062
Method for the improvement of skin wrinkles using retinyl retinoate
granted -
US 7172876
Method of screening therapeutic agents for nerve degeneration associated diseases
granted -
US 7172770
Mesoporous compositions for use in drug delivery
granted
Frequently asked questions
How many pharma patents expire in 2027?
578 published patents in our USPTO index have expiration dates falling in calendar year 2027.